South and Central America Extracellular Matrix Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application (Vascular Repair and Reconstruction, Dural Repair, Wound Healing, Cardiac Repair, Pericardial Repair, Soft Tissue Repair); Raw Material (Bovine, Porcine, Other Raw Material), and Country
The South and Central America extracellular matrix market was valued at US$ 989.99 thousand in 2019 and is projected to reach US$ 11,708.44 thousand by 2027; it is expected to grow at a CAGR of 7.1% from 2020 to 2027.
The growth of the market is attributed to the increasing incidences of trauma and cardiovascular diseases, and increasing vascular reconstruction procedures. However, the challenges associated with the usage of decellularized extracellular matrix such as , insufficient preservation of vasculature and extracellular matrix composition hinders the growth of the market.
The significantly rising incidences of the orthopaedic trauma conditions and cardiovascular diseases among others are the leading factors for the South and Central America Extracellular Matrix market growth. As a part of the treatment extracellular matrix serve several advantages for treating different chronic injuries caused due to surgery, accidents, chronic diseases and others. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability. The awareness about the technologically advanced treatment and minimally invasive procedures demands treatments that are effective in less time. Thus, one of the advantages of the extracellular matrix serve the demand of the patients.
Additionally, the COVID-19 outbreak is negatively impacting the overburdened and underfunded healthcare systems of South and Central America. Hospitals are already overstressed by the treatment of vector‐borne diseases and community‐acquired infections and high rates of non‐communicable diseases (NCDs). Since the onset of the COVID-19, the prevention and treatment of NCDs such as diabetes and its associated complications have been critically affected in the region, as per the Pan American Health Organization (PAHO).
South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (US$ Thousand)
Get more information on this report :
South and Central America Extracellular Matrix Market Segmentation
By Application
- Vascular Repair and Reconstruction
- Dural Repair
- Wound Healing
- Cardiac Repair
- Pericardial Repair
- Soft Tissue Repair
By Raw Material
- Bovine
- Porcine
- Other Raw Material
Company Profiles
- Organogenesis Inc.
- Integra Life Sciences Corporation
- Mölnlycke Health Care AB
- Anika Therapeutics, Inc.
- ACell Inc.
- MIROMATRIX MEDICAL Inc
- Acera Surgical Inc., CorMatrix, Inc.
- Hollister Incorporated
- MLM Biologics Inc.
- Harbor MedTech, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Extracellular Matrix Market – By Application
1.3.2 Extracellular Matrix Market – By Raw Material
1.3.3 South and Central America Extracellular Matrix Market
2. Extracellular Matrix Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Extracellular Matrix Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South and Central America – PEST Analysis
4.3 Expert Opinion
5. South and Central America Extracellular Matrix Market Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Incidences of Trauma and Cardiovascular Diseases
5.1.2 Increasing Vascular Reconstruction Procedures
5.2 Key Market challenge
5.2.1 Challenges Associated with the Usage of Decellularized Extracellular Matrix
5.3 Key Market Opportunity
5.3.1 Opportunities to Treat Cancer
5.4 Future Trend
5.4.1 3D Printing in Wound Care Management
5.5 Impact analysis
6. Extracellular Matrix Market – South and Central America Analysis
6.1 South and Central America Extracellular Matrix market Revenue Forecasts and Analysis (us$ Thousand)
6.3 Market Positioning of Key Players
7. South and Central America Extracellular Matrix Market Analysis – By Application
7.1 Overview
7.2 South and Central America Extracellular Matrix Market Shares By Application, 2019 & 2027 (%)
7.3 VASCULAR REPAIR AND RECONSTRUCTION MARKET
7.3.1 Overview
7.3.2 Vascular Repair and Reconstruction Market: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.4 DURAL REPAIR MARKET
7.4.1 Overview
7.4.2 Dural Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.5 WOUND HEALING MARKET
7.5.1 Overview
7.5.2 Wound Healing: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.6 CARDIAC REPAIR MARKET
7.6.1 Overview
7.6.2 Cardiac Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.7 PERICARDIAL REPAIR MARKET
7.7.1 Overview
7.7.2 Pericardial Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
7.8 SOFT TISSUE REPAIR MARKET
7.8.1 Overview
7.8.2 Soft Tissue Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8. South and Central America Extracellular Matrix Market Analysis – By Raw Material
8.1 Overview
8.2 South and Central America Extracellular Matrix Market Shares By Raw Material, 2019 & 2027 (%)
8.3 BOVINE MARKET
8.3.1 Overview
8.3.2 Bovine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8.4 PORCINE MARKET
8.4.1 Overview
8.4.2 Porcine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
8.5 OTHERS MARKET
8.5.1 Overview
8.5.2 Others: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
9. South and Central America Extracellular Matrix Market Revenue and Forecasts to 2027
9.1 Overview
9.1.1 South and Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.2 South and Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.3 South and Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.4 South and Central America: Extracellular Matrix Market, by Country, 2019 & 2027 (%)
9.1.5 Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.5.1 Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.6 Brazil Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.7 Brazil Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.8 Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.8.1 Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.9 Argentina Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.10 Argentina Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.11 Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.11.1 Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.12 Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13 Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.1 El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.2 El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.3 El Salvador Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.4 El Salvador Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.5 Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.6 Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.7 Guatemala Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.8 Guatemala Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.9 Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.10 Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.11 Rest of Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.13.12 Rest of Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
9.1.14 Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.14.1 Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
9.1.15 Rest of South America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
9.1.16 Rest of South America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
10. Impact of COVID-19 Pandemic on South and Central America Extracellular Matrix Market
10.1 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Extracellular Matrix Market – Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Organogenesis Inc.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Integra Life Sciences Corporation
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Mölnlycke Health Care AB.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Anika Therapeutics, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 ACell Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 MIROMATRIX MEDICAL Inc
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Acera Surgical Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 CorMatrix, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Hollister Incorporated
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.10 MLM Biologics Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Harbor MedTech, Inc.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 2. South and Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 3. Brazil Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 4. Brazil Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 5. Argentina Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 6. Argentina Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 7. Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 8. Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 9. El Salvador Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 10. El Salvador Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 11. Guatemala Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 12. Guatemala Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 13. Rest of Central America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 14. Rest of Central America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 15. Rest of South America Extracellular Matrix Market, by Application – Revenue and Forecast to 2027 (USD Thousand)
Table 16. Rest of South America Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2027 (USD Thousand)
Table 17. Organic Developments Done By Companies
Table 18. Inorganic Developments Done By Companies
Table 19. Glossary of Terms, Extracellular Matrix market
LIST OF FIGURES
Figure 1. Extracellular Matrix Market Segmentation
Figure 2. Extracellular Matrix Market– By Geography
Figure 3. South and Central America Extracellular Matrix Market Overview
Figure 4. Soft Tissue Repair Segment Held Largest Share of Extracellular Matrix Market
Figure 5. Brazil Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. South and Central America Extracellular Matrix Market, Industry Landscape
Figure 7. South and Central America PEST Analysis
Figure 8. Extracellular Matrix market impact analysis of driver and restraints
Figure 9. South and Central America Extracellular Matrix market – Revenue Forecasts and Analysis – 2019- 2027 (US$ Thousand)
Figure 10. Market Positioning of Key Players
Figure 11. South and Central America Extracellular Matrix market Shares By Application, 2019 & 2027 (%)
Figure 12. Vascular Repair and Reconstruction Market: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 13. Dural Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 14. Wound Healing: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 15. Cardiac Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 16. Pericardial Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 17. Soft Tissue Repair: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 18. South and Central America Extracellular Matrix Market Shares By Raw Material, 2019 & 2027 (%)
Figure 19. Bovine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 20. Porcine: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 21. Others: Extracellular Matrix Market– Revenue and Forecast to 2027 (US$ Thousand)
Figure 22. South and Central America: Extracellular Matrix Market, by Key Country – Revenue (2019) (USD Million)
Figure 23. South and Central America Extracellular Matrix Market Revenue and Forecast to 2027 (USD Thousand)
Figure 24. South and Central America: Extracellular Matrix Market, by Country, 2019 & 2027 (%)
Figure 25. Brazil: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 26. Argentina: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 27. Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 28. El Salvador: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 29. Guatemala: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 30. Rest of Central America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 31. Rest of South America: Extracellular Matrix Market – Revenue and Forecast to 2027 (USD Thousand)
Figure 32. Impact of COVID-19 Pandemic on Extracellular Matrix Market in South and Central America
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - South and Central America Extracellular Matrix Market
- Organogenesis Inc.
- Integra Life Sciences Corporation
- Mölnlycke Health Care AB
- Anika Therapeutics, Inc.
- ACell Inc.
- MIROMATRIX MEDICAL Inc
- Acera Surgical Inc., CorMatrix, Inc.
- Hollister Incorporated
- MLM Biologics Inc.
- Harbor MedTech, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America extracellular matrix market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America extracellular matrix market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.